Nuclear localizing sequences: An innovative way to improve targeted radiotherapy

Journal of Nuclear Medicine

Volumn 47, Issue 5, 2006, Pages 738-739

  O'Donnell, Robert T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Northern California Veteran's Healthcare System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMTUZUMAB OZOGAMICIN; HUM 195; IMMUNOGLOBULIN G ANTIBODY; INDIUM 111; IODINE 131; MONOCLONAL ANTIBODY; RADIOISOTOPE; UNCLASSIFIED DRUG; YTTRIUM 90; RADIOPHARMACEUTICAL AGENT;

BONE MARROW TOXICITY; CANCER; CANCER CELL; CANCER RADIOTHERAPY; CYTOTOXICITY; DRUG CLEARANCE; DRUG TARGETING; HUMAN; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; SHORT SURVEY; CHEMISTRY; METHODOLOGY; NEOPLASM; NOTE; ONCOLOGY; RADIOTHERAPY;

HUMANS; NEOPLASMS; RADIATION ONCOLOGY; RADIOISOTOPES; RADIOPHARMACEUTICALS; RADIOTHERAPY;

EID: 33745537078     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. 111In in human myeloid leukemia cells. J Nucl Med. 2006;47:827-836.
2. Larson RA, Sievers EL, Stadtmauer EA, et al. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer. 2005;104:1442-1452.
3. Leonard JP. Targeting CD20 in Follicular NHL: Novel anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates. Hematology (American Society of Hematology Education Program Book). Atlanta, GA; December 10-13, 2005:335-339.
4. Goddu SM, Howell RW, Rao DV. Cellular dosimetry: absorbed fractions for monoenergetic electron and alpha particle sources and S-values for radionuclides uniformly distributed in different cell compartments. J Nucl Med. 1994;35:303-316.
5. Kassis A. The amazing world of Auger electrons. Int J Radiat Biol. 2004;80:789-803.